Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2/3 copy number variation in Plasmodium falciparum

Abstract Background Long regarded as an epicenter of drug-resistant malaria, Southeast Asia continues to provide new challenges to the control of Plasmodium falciparum malaria. Recently, resistance to the artemisinin combination therapy partner drug piperaquine has been observed in multiple location...

Full description

Bibliographic Details
Main Authors: Megan R. Ansbro, Christopher G. Jacob, Roberto Amato, Mihir Kekre, Chanaki Amaratunga, Sokunthea Sreng, Seila Suon, Olivo Miotto, Rick M. Fairhurst, Thomas E. Wellems, Dominic P. Kwiatkowski
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Malaria Journal
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12936-020-03249-x
_version_ 1818519304826519552
author Megan R. Ansbro
Christopher G. Jacob
Roberto Amato
Mihir Kekre
Chanaki Amaratunga
Sokunthea Sreng
Seila Suon
Olivo Miotto
Rick M. Fairhurst
Thomas E. Wellems
Dominic P. Kwiatkowski
author_facet Megan R. Ansbro
Christopher G. Jacob
Roberto Amato
Mihir Kekre
Chanaki Amaratunga
Sokunthea Sreng
Seila Suon
Olivo Miotto
Rick M. Fairhurst
Thomas E. Wellems
Dominic P. Kwiatkowski
author_sort Megan R. Ansbro
collection DOAJ
description Abstract Background Long regarded as an epicenter of drug-resistant malaria, Southeast Asia continues to provide new challenges to the control of Plasmodium falciparum malaria. Recently, resistance to the artemisinin combination therapy partner drug piperaquine has been observed in multiple locations across Southeast Asia. Genetic studies have identified single nucleotide polymorphisms as well as copy number variations in the plasmepsin 2 and plasmepsin 3 genes, which encode haemoglobin-degrading proteases that associate with clinical and in vitro piperaquine resistance. Results To accurately and quickly determine the presence of copy number variations in the plasmepsin 2/3 genes in field isolates, this study developed a quantitative PCR assay using TaqMan probes. Copy number estimates were validated using a separate SYBR green-based quantitative PCR assay as well as a novel PCR-based breakpoint assay to detect the hybrid gene product. Field samples from 2012 to 2015 across three sites in Cambodia were tested using DNA extracted from dried blood spots and whole blood to monitor the extent of plasmepsin 2/3 gene amplifications, as well as amplifications in the multidrug resistance transporter 1 gene (pfmdr1), a marker of mefloquine resistance. This study found high concordance across all methods of copy number detection. For samples derived from dried blood spots, a success rate greater than 80% was found in each assay, with more recent samples performing better. Evidence of extensive plasmepsin 2/3 copy number amplifications was observed in Pursat (94%, 2015) (Western Cambodia) and Preah Vihear (87%, 2014) (Northern Cambodia), and lower levels in Ratanakiri (16%, 2014) (Eastern Cambodia). A shift was observed from two copies of plasmepsin 2 in Pursat in 2013 to three copies in 2014–2015 (25% to 64%). Pfmdr1 amplifications were absent in all samples from Preah Vihear and Ratanakiri in 2014 and absent in Pursat in 2015. Conclusions The multiplex TaqMan assay is a robust tool for monitoring both plasmepsin 2/3 and pfmdr1 copy number variations in field isolates, and the SYBR-green and breakpoint assays are useful for monitoring plasmepsin 2/3 amplifications. This study shows increasing levels of plasmepsin 2 copy numbers across Cambodia from 2012 to 2015 and a complete reversion of multicopy pfmdr1 parasites to single copy parasites in all study locations.
first_indexed 2024-12-11T01:22:23Z
format Article
id doaj.art-cfde5d3cf9664bcc85c2c6203d93a43f
institution Directory Open Access Journal
issn 1475-2875
language English
last_indexed 2024-12-11T01:22:23Z
publishDate 2020-05-01
publisher BMC
record_format Article
series Malaria Journal
spelling doaj.art-cfde5d3cf9664bcc85c2c6203d93a43f2022-12-22T01:25:40ZengBMCMalaria Journal1475-28752020-05-0119111010.1186/s12936-020-03249-xDevelopment of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2/3 copy number variation in Plasmodium falciparumMegan R. Ansbro0Christopher G. Jacob1Roberto Amato2Mihir Kekre3Chanaki Amaratunga4Sokunthea Sreng5Seila Suon6Olivo Miotto7Rick M. Fairhurst8Thomas E. Wellems9Dominic P. Kwiatkowski10Wellcome Sanger InstituteWellcome Sanger InstituteWellcome Sanger InstituteWellcome Sanger InstituteLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of HealthNational Center for Parasitology, Entomology, and Malaria ControlNational Center for Parasitology, Entomology, and Malaria ControlWellcome Sanger InstituteLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of HealthLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of HealthWellcome Sanger InstituteAbstract Background Long regarded as an epicenter of drug-resistant malaria, Southeast Asia continues to provide new challenges to the control of Plasmodium falciparum malaria. Recently, resistance to the artemisinin combination therapy partner drug piperaquine has been observed in multiple locations across Southeast Asia. Genetic studies have identified single nucleotide polymorphisms as well as copy number variations in the plasmepsin 2 and plasmepsin 3 genes, which encode haemoglobin-degrading proteases that associate with clinical and in vitro piperaquine resistance. Results To accurately and quickly determine the presence of copy number variations in the plasmepsin 2/3 genes in field isolates, this study developed a quantitative PCR assay using TaqMan probes. Copy number estimates were validated using a separate SYBR green-based quantitative PCR assay as well as a novel PCR-based breakpoint assay to detect the hybrid gene product. Field samples from 2012 to 2015 across three sites in Cambodia were tested using DNA extracted from dried blood spots and whole blood to monitor the extent of plasmepsin 2/3 gene amplifications, as well as amplifications in the multidrug resistance transporter 1 gene (pfmdr1), a marker of mefloquine resistance. This study found high concordance across all methods of copy number detection. For samples derived from dried blood spots, a success rate greater than 80% was found in each assay, with more recent samples performing better. Evidence of extensive plasmepsin 2/3 copy number amplifications was observed in Pursat (94%, 2015) (Western Cambodia) and Preah Vihear (87%, 2014) (Northern Cambodia), and lower levels in Ratanakiri (16%, 2014) (Eastern Cambodia). A shift was observed from two copies of plasmepsin 2 in Pursat in 2013 to three copies in 2014–2015 (25% to 64%). Pfmdr1 amplifications were absent in all samples from Preah Vihear and Ratanakiri in 2014 and absent in Pursat in 2015. Conclusions The multiplex TaqMan assay is a robust tool for monitoring both plasmepsin 2/3 and pfmdr1 copy number variations in field isolates, and the SYBR-green and breakpoint assays are useful for monitoring plasmepsin 2/3 amplifications. This study shows increasing levels of plasmepsin 2 copy numbers across Cambodia from 2012 to 2015 and a complete reversion of multicopy pfmdr1 parasites to single copy parasites in all study locations.http://link.springer.com/article/10.1186/s12936-020-03249-xMalariaPiperaquinePlasmepsinqPCRCambodiaCopy number
spellingShingle Megan R. Ansbro
Christopher G. Jacob
Roberto Amato
Mihir Kekre
Chanaki Amaratunga
Sokunthea Sreng
Seila Suon
Olivo Miotto
Rick M. Fairhurst
Thomas E. Wellems
Dominic P. Kwiatkowski
Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2/3 copy number variation in Plasmodium falciparum
Malaria Journal
Malaria
Piperaquine
Plasmepsin
qPCR
Cambodia
Copy number
title Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2/3 copy number variation in Plasmodium falciparum
title_full Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2/3 copy number variation in Plasmodium falciparum
title_fullStr Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2/3 copy number variation in Plasmodium falciparum
title_full_unstemmed Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2/3 copy number variation in Plasmodium falciparum
title_short Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2/3 copy number variation in Plasmodium falciparum
title_sort development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2 3 copy number variation in plasmodium falciparum
topic Malaria
Piperaquine
Plasmepsin
qPCR
Cambodia
Copy number
url http://link.springer.com/article/10.1186/s12936-020-03249-x
work_keys_str_mv AT meganransbro developmentofcopynumberassaysfordetectionandsurveillanceofpiperaquineresistanceassociatedplasmepsin23copynumbervariationinplasmodiumfalciparum
AT christophergjacob developmentofcopynumberassaysfordetectionandsurveillanceofpiperaquineresistanceassociatedplasmepsin23copynumbervariationinplasmodiumfalciparum
AT robertoamato developmentofcopynumberassaysfordetectionandsurveillanceofpiperaquineresistanceassociatedplasmepsin23copynumbervariationinplasmodiumfalciparum
AT mihirkekre developmentofcopynumberassaysfordetectionandsurveillanceofpiperaquineresistanceassociatedplasmepsin23copynumbervariationinplasmodiumfalciparum
AT chanakiamaratunga developmentofcopynumberassaysfordetectionandsurveillanceofpiperaquineresistanceassociatedplasmepsin23copynumbervariationinplasmodiumfalciparum
AT sokuntheasreng developmentofcopynumberassaysfordetectionandsurveillanceofpiperaquineresistanceassociatedplasmepsin23copynumbervariationinplasmodiumfalciparum
AT seilasuon developmentofcopynumberassaysfordetectionandsurveillanceofpiperaquineresistanceassociatedplasmepsin23copynumbervariationinplasmodiumfalciparum
AT olivomiotto developmentofcopynumberassaysfordetectionandsurveillanceofpiperaquineresistanceassociatedplasmepsin23copynumbervariationinplasmodiumfalciparum
AT rickmfairhurst developmentofcopynumberassaysfordetectionandsurveillanceofpiperaquineresistanceassociatedplasmepsin23copynumbervariationinplasmodiumfalciparum
AT thomasewellems developmentofcopynumberassaysfordetectionandsurveillanceofpiperaquineresistanceassociatedplasmepsin23copynumbervariationinplasmodiumfalciparum
AT dominicpkwiatkowski developmentofcopynumberassaysfordetectionandsurveillanceofpiperaquineresistanceassociatedplasmepsin23copynumbervariationinplasmodiumfalciparum